Sivik Global Healthcare LLC Coherus Bio Sciences, Inc. Transaction History

Sivik Global Healthcare LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$16.33 - $21.37 $739,683 - $967,975	-45,296 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$16.3 - $23.37 $1.63 Million - $2.33 Million	-99,704 Reduced 68.76%	45,296 $918,000
Q2 2019 Aug 14, 2019	SELL	$13.1 - $22.1 $1.05 Million - $1.77 Million	-80,000 Reduced 35.56%	145,000 $3.2 Million
Q1 2019 May 08, 2019	BUY	$8.38 - $15.5 $1.89 Million - $3.49 Million	225,000 New	225,000 $3.07 Million
Q4 2018 Feb 12, 2019	SELL	$8.65 - $16.28 $857,223 - $1.61 Million	-99,101 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$14.45 - $20.25 $12,990 - $18,204	-899 Reduced 0.9%	99,101 $1.64 Million
Q2 2018 Aug 06, 2018	BUY	$10.25 - $17.45 $1.03 Million - $1.75 Million	100,000 New	100,000 $1.4 Million

138

78M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $99.5M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

Stay updated on Sivik Global Healthcare LLC with notifications on news.